1 / 16

Innovative Financing for Health in the Asia-Pacific

Innovative Financing for Health in the Asia-Pacific. APLMA Regional Financing for Malaria Task Force May 12, 2014. Jenny Liu, PhD Malaria Elimination Initiative The Global Health Group University of California, San Francisco. Contributors: Cambridge Economic and Policy Associates

juan
Download Presentation

Innovative Financing for Health in the Asia-Pacific

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Innovative Financing for Health in the Asia-Pacific APLMA Regional Financing for Malaria Task Force May 12, 2014 Jenny Liu, PhD Malaria Elimination Initiative The Global Health Group University of California, San Francisco Contributors: Cambridge Economic and Policy Associates Clinton Health Access Initiative

  2. Donor funding for malaria has declined since 2009 • Donor funding for Asia-Pacific countries was 12-21% of the total global malaria financing from 2006 to 2010, but was only 6% in 2011. Change in USD/year in malaria development assistance (2006-2011) Malaria development assistance across regions • Source: IHME Financing Global Health Database, released 4/2014

  3. Malaria programs in the Asia-Pacific are heavily dependent on donor funding • The Global Fund has provided 30% of all country malaria program funding in the Asia-Pacific from 2006-2010 • Other external donors (mulit- and bilateral) accounted for 32% of all financing • Mainly from the US, UK, Australia, and Japan Sources of malaria program financing for Asia Pacific countries (2006-2010) $304m $429m $264m • Domestic governments contributed 38% • 31% among malaria control countries • 47% among malaria-eliminating countries $409m $497m $379m Source: UCSF GHG calculations of data from Pigott et al. (2012)

  4. Substantial gaps in funding exist • At least 35% of the total need is projected to be unfunded through 2015, and likely more given GF NFM allocations Estimated malaria program costs through 2030 in the Asia-Pacific 1Notes: 2008 GMAP estimate from Malaria 2012 Background paper #2. Cumulate estimates for malaria-eliminating countries are taken from Zelman et al. 2014. Model assumptions differ; please see source documents for model specifications.

  5. Potential impact of the Global Fund NFMExample from the Asia-Pacific malaria-eliminating countries

  6. The APLMA Regional Trust Fund is vital to sustaining efforts Warning! • Malaria program disruptions have led to malaria resurgences • Cannot afford to reduce efforts, particularly with the risk of spreading artemisinin resistance Source: Cohen et al. 2012 Malaria Journal

  7. Malaria elimination is the universal goal • Artemisinin resistance now in 6 areas of the Mekong, and spreading • Delayed parasite clearance reported in Suriname, Nigeria, and Kenya • Evidence resistance in Angola • Within the Mekong, eliminatingP. falciparumis the answer to artemisinin resistance • Elimination is the collective goal of countries outside the Mekong • Two vanguards in this effort:

  8. Asia Pacific Malaria Elimination Network • 15 countries with a goal of national or sub-national elimination • 30 partner institutions relevant to elimination • Country-led, country-driven – direction & annual work plans • Objectives: Information-sharing, capacity building, building the evidence base for elimination, and advocacy

  9. Role for the Regional Trust Fund • Support countries unable to fund their own programs • Especially important for countries whose GF support will decline • Incentivize countries nearing elimination to maintain/accelerate efforts • E.g. reducing cross-border risk, technical assistance, eliminating Pf in resistance countries • Finance activities that produce regional public goods • Diagnostic tools, surveillance, data of decision making, collaboration across sectors and countries, quality of pharmaceuticals, HR capacity building, operational research • Fund assessment of health impacts and risk mitigation • Need to measure progress • Generate evidence to demonstrate ROI

  10. Sustainability is key to the Trust Fund Fundraising instruments Sources of finance • Market financing / debt raising mechanisms: • IFFIm • Social impact or pay for performance bonds – e.g. proposed malaria bond in Mozambique • Debt / credit conversion mechanisms: • Debt2Health • Performance-based credit buy-down • Endowment Funds: Gates Foundation, Rockefeller endowments • International earmarked taxes and levies: UNITAID • Regional funds: • Malaria Control Fund of the Gulf Cooperation Council Central Asian Countries Initiative for Land Management • Private sector resources: • Corporate social responsibility • Profit-sharing mechanisms: Product RED campaign • Public-Private Partnerships – global funding mechanisms such as the Emerging Africa Infrastructure Fund • Major foundations and other philanthropic funding: Gates Foundation, Rockefeller, Rotary • Emerging government donors: BRICs, East Asian countries including South Korea, Brunei and Malaysia. • Voluntary contributions: lotteries, mobile phone solidarity contributions

  11. Applicability of mechanisms to malaria elimination

  12. Structural considerations • Funding mechanism features • All countries should be able to access the fund, not just high burden countries • Align timing with national budget cycle • Government, CSO, and private sector should be eligible to be recipients • Accountability features • Results-based • Independent M&E system • Leverage ADB’s capacity and credibility, particularly for countries with less domestic capacity to manage funds

  13. Cash-on-delivery (COD) is well-suited for accelerating Pf elimination in the Mekong and regionally • Key Features of COD • Improved Outcomes: Countries are incentivized to maximize results – optimizing impact, rather than input • Increased Efficiency: COD rewards depend only upon independently verified outcomes, eliminating the transaction costs of interim reporting • Country Ownership: COD funding is unrestricted and a country must decide how to spent it, increasing programmatic ownership • Low Donor Risk: Payment is only made upon performance, maximizing value-for-money • A COD contract is an agreement between a donor and a recipient country where the country will receive a financial award for achievement of a pre-agreed indicator of progress. • Currently being piloted by Global Fund in health and DFID in education • Could eliminate complex grant indicators and intensely focus on impact towards elimination

  14. The Global Fund has designed its first COD grant in Central America for malaria elimination The Grant - $10M for Malaria Indicator • “Eliminacion de la Malaria en Mesoamerica y la Hispaniola” • Panama, Costa Rica, Nicaragua, Honduras, El Salvador, Guatemala, Belize, Haiti & Dom. Republic • Local Cases of Malaria • Singular indicator in WHO definition of elimination • Uses country systems • Unites region around common goal The Model • In Year 1, all countries receive start-up money to improve surveillance systems • In Year 2 and 3, successful countries receive $600k reimbursement for any government malaria expense from previous year Reward Payout • $600,000 • Per country, per year • Calculated by dividing funds across two years for all countries Quality Assurance • The PR’s main role is to verify results (annually) • Analyzes accuracy of data, and potential for fraud/misrepresentation

  15. Measuring progress in the Asia Pacific Within 1 day All suspected fever cases laboratory/ clinically diagnosed and reported China’s 1-3-7 strategy for surveillance and response • Choose simple indicators: • Many countries already use cases as a metric to measure program performance • Others could be considered for different phases (e.g. China’s 1-3-7) • COD grants could use existing measurement systems, but would require an external verification • In a regional scheme, these data could be shared to help border states better react to outbreaks in neighboring countries Within 3 days Conduct case investigation, confirm case by double microscopy & PCR, classify as imported vs. local Within 7 days Conduct focus investigation, reactive case detection, IRS, health education Source: Cao et al. 2015 PlosMed

  16. Priority considerations • Clear focus for immediate future: malaria elimination is necessary for combatting artemisinin resistance • Expanding the resource pool: need convincing business case for why the trust fund is interesting for (1) traditional donors, (2) emerging donors, and (3) private sector businesses and foundations • Prioritizing disbursements: Stop-gap funding for “crisis” countries to sustain program efforts • Clear messaging and speed: to instill confidence and buy-in from member countries

More Related